ESHAML2025
7th International Conference: Acute Myeloid Leukemia "Molecular and Translational": Advances in Biology and Treatment Estoril, Portugal Presentations by CMYC participants at the conferences
7th International Conference: Acute Myeloid Leukemia "Molecular and Translational": Advances in Biology and Treatment Estoril, Portugal Presentations by CMYC participants at the conferences
Welcome to the upcoming seminar holdt by Professor Ole Morten Seternes, Group Leader of the Cell Signalling and Targeted Therapy Research Group, Department of Pharmacy, UIT The Arctic University of Norway. Tittle: The dual specificity MAP kinase phosphatase DUSP2 acts as distal regulatory node in T Cell signalling Time: 22nd October 2025. 14:00 - 15:00 READ MORE
"Stress for success”: Unlocking Venetoclax sensitivity in T-ALL through the mTORC1–ISR–BMF axis. by Prof. Vincenzo Ciminale, MD, Istituto Oncologico Veneto, Padova, Italy When: Thursday, 13.11.2025, 14.30–15.30 Where: Aud. 4, BBB Host: Bjørn Tore Gjertsen Abstract Refractory/relapsed T-cell acute lymphoblastic leukemia (R/R T-ALL) remains a major therapeutic challenge at present. Our recent studies showed that inhibition of mTORC1 markedly sensitizes READ MORE
Tara Helén Steinsland Dowling is presenting and defending for ph.d.-degree with her thesis "Acute myeloid leukemia at single-cell resolution: Clonal heterogeneity in precision therapy" Trial lecture: "Relevance of clonal hematopoiesis in hematological malignancies" Time: 10.15–11.00 Place: HUS - BB-bygget, Auditorium 2 Defense Time: 12.15–15.00 Location: HUS - BB-bygget, Auditorium 2 For more information: https://www.uib.no/nye-doktorgrader/180253/krigen-mellom-klonane-det-klonale-landskapet-i-aml
You are invited to join a distinguished academic webinar featuring Prof. Dr. med. Lars Bullinger and Prof. Bjørn Tore Gjertsen, two leading experts in hematology and leukemia research. The webinar is hosted by Jazz Pharmaceuticals For registration: Please sign up using this Link
The next coming CMYC Lab Retreat will be held on February 12–13, 2026 at Solstrand Hotel & Bad, Bergen. At the retreat, Master’s students, PhD candidates, and postdocs/researchers in CMYC will present and discuss about their thesis or project. The purpose of the retreat is to strengthen team building through interaction between junior and senior members, READ MORE
Inga Kirstine Flaaten Motzfeldt is presenting and defending for ph.d.-degree at the University of Bergen, with her thesis "Exploration of Disease Mechanisms and Targeted Therapies in Acute Myeloid Leukemia". Time: 12.15–15.00 Location: HUS - BB-bygget, Auditorium 1 Trial lecture: "Functional Precision Oncology – Phosphoproteomics-guided targeting of oncogenic kinases in AML" Time: 10.15–11.00 Place: HUS - READ MORE
Avenue: Auditorium 4, BB-bygget 10:15 –11:00 Assoc. Prof. Francesca Sacco, Department of Biology, University of Rome Tor Vergata“A systems biology approach to identify vulnerabilities in therapy-resistant leukemias“ 11:00 – 12:00 Assoc. Prof. Kim Theilgaard-Mönch, Biotech Research & Innovation Centre, University of Copenhagen"The glycosaminoglycan oncofetal chondroitin sulfate represents a novel target for antibody drug-conjugate therapy of acute myeloid leukemia" For READ MORE
MRD in AML — what, where, when, and does it matter? Speaker: Richard Dillon, Clinical Senior Lecturer in Cancer Genetics in the Department of Medical & Molecular Genetics, School of Basic & Medical Biosciences, at King's College London and Consultant Haematologist at Guy’s Hospital, London, UK Place: Auditorium 4, BB-building When: April 23, 2026, at 14.30–15.30 Chair: READ MORE
More info: please visit SBMC 2026
EHA 2026 - 31st Congress of the European Hematology Association 2026 11th – 14th June, 2026 Stockholmsmässan, Stockholm, Sweden More info: EHA2026